Comparison of Thrombgolytic and Anticoagulation Therapy in Submassive Pulmonary Embolism

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT02132689

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02132689
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Czechia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02132689. Non-randomized; no masking; primary purpose treatment. Start 2011-03 (actual); primary completion 2015-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Thrombgolytic and Anticoagulation Therapy in Submassive Pulmonary Embolism
Acronym
CONTACT-SPE
Intervention (Drug)
Actilyse (Thrombolytic therapy)
Intervention (Drug)
Heparine (Standard anticoagulation therapy)
Lead sponsor
University Hospital Ostrava (class: other)
Collaborator
Municipal Hospital Ostrava Fifejdy (class: not stated)
Collaborator
Silesian Hospital Opava (class: not stated)

Record details

Record id
cardio:ct-nct02132689
Content hash
64662212dcf627377900749b96122cd86daf45257000f83a485d3d243afe6599